MISBA
LIVE

Serial Number

79440214

Owner

Harness Therapeutics Limited

Filing Date

Nov 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MISBA Trademark

Serial Number: 79440214

MISBA is a trademark filed by Harness Therapeutics Limited on November 26, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Harness Therapeutics Limited (4 trademarks)

Minerva Building (B250),

Entity Type: 98

Trademark Details

Filing Date

November 26, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations; medical and veterinary preparations for therapeutic purposes; biological, chemical and biochemical reagents for medical use; DNA, RNA, oligonucleotides, polynucleotides for medical and veterinary use; gene editing enzymes for medical and veterinary use; medical and veterinary preparations containing therapeutic DNA and RNA; pharmaceutical research tools in the nature of biological, chemical and biochemical reagents.

Scientific and technological services and research and design relating thereto; medical and veterinary research services including the manipulation of biological reagents to be used for medical, veterinary or therapeutic purposes; chemical and biological analysis and research services; research into DNA and RNA; research and development into the creation of DNA and RNA; research and development services in the manufacture of synthetic DNA, RNA, genes and oligonucleotides for others; research, development, testing and analysis in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene-editing services; DNA and RNA modelling services; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; research and development services in creating libraries or collections of normal and mutated genes; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; consultancy and advisory services relating to the aforesaid services.

Chemicals for scientific purposes; chemicals for use in research; chemicals, enzymes, biological preparations in the nature of DNA and RNA for research use; chemicals for use in the preparation and creation of DNA and RNA; enzymes for use in the preparation and creation of DNA and RNA; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use.

Filing History

REFUSAL PROCESSED BY IB
Jun 4, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 15, 2026 RFCS
REFUSAL PROCESSED BY MPU
May 14, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 31, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 30, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 4, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 25, 2025 REPR